Suja Life is trading at $9.60, up 6.08%, with no company-specific news explicitly linked to the move.
- On October 2, CNBC reported Roth initiated coverage with a Buy rating and a $20 12-month price target, citing expected double-digit growth; the report did not connect the call to the price change.
- The broader market was also higher in the provided market context, which may support the move, but available evidence does not establish a direct cause.